Yes, the vaccination doesn't provide 100% protection.
Meningococcal Meningitis, which can be vaccinated against, lasts from 2 to 10 (commonly 3 to 4) days, symptoms include Headache, nausea, stiff neck, fever. Minimum exclusion from others is until physician permits return.
A Meningo vaccine is a vaccine against the bacterium Neisseria Meningitidis (Meningococcus). One of the main causative organisms of Meningitis and Meningococcal Septicaemia.
The most effective weapon against bacterial meningitis is vaccination. Recommended vaccinations can help prevent certain types of bacterial meningitis like pneumococcal meningitis, meningococcal meningitis, and Haemophilus influenzae type b meningitis. It is important to consult with a healthcare provider for specific recommendations based on individual risk factors.
One dose of the meningococcal vaccine significantly reduces the risk of contracting meningitis caused by certain strains of the bacteria Neisseria meningitidis, but it does not provide complete protection against all strains or types of meningitis. Booster doses may be required for sustained immunity, and individuals should follow local health guidelines for vaccination schedules. It's important to consult healthcare providers for personalized advice on vaccination.
Prevention of meningitis involves vaccination against certain types of bacteria and viruses that can cause the infection, maintaining good hygiene practices such as washing hands regularly, avoiding sharing items that come into contact with saliva, and seeking prompt medical treatment for infections that can potentially lead to meningitis. It is also essential to address risk factors such as a weakened immune system or close contact with someone who has meningitis.
It is a vaccine for the prevention of bacterial meningococcal disease and meningitis (infection of the covering of the brain and spinal cord).From manufacturer package literature:"Menactra vaccine is indicated for active immunization to prevent invasive meningococcal disease caused by N meningitidis serogroups A, C, Y, and W-135. Menactra vaccine is approved for use in individuals 9 months through 55 years of age. Menactra vaccine does not prevent N meningitidis serogroup B disease. "
Meningococcal disease, like most bacterial infections, is treated with antibiotics. Some antibiotics which are effective against it are benzylpenicillin and cefotaxime.
Babies are vaccinated to protect against common diseases until their immune systems are developed.
Smallpox and polio. There are several other diseases that are vaccinated against - whooping cough to name just one.
Smallpox and polio. There are several other diseases that are vaccinated against - whooping cough to name just one.
It is a vaccine against meningitis in young children
Robert Koch